B-Soft Co Ltd (300451) fair value: what the stock is really worth
As of Nov 20, 2026: fair value (intrinsic value) of B-Soft Co Ltd stock ¥2.81, price ¥2.82, that is 0.4% below the price, quality 36 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently applies, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
B-Soft Co Ltd
300451 · SHEThe stock is already about fairly priced, weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range ¥2.82 – ¥11.52 · fair‑value band ¥2.11 – ¥3.51 · the ¥2.82 price screens above the ¥2.81 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether B-Soft Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
B-SOFT Co.,Ltd. operates in the healthcare information technology industry in China. The company offers Huikang·Yunshu Intelligent Body, a medical AI agent of Huikang.
Show moreShow less
It also provides outpatient registration and appointment center, medical technology appointment center, inpatient and outpatient services, and hospital cloud platform; and big data and artificial intelligence, hospital-wide medical-technical integration, mobile intelligent healthcare, hospital multidisciplinary consultation, clinical decision, b-soft overall solution for epidemic prevention and control, and Hi-HIS. In addition, the company offers management decision support, intelligent comprehensive management, hospital medical insurance risk management, performance management, intelligent management application, refined management system for low value consumables, consumables traceability management system, and consumables trading supervision and drug trade supervision platform; and intelligent IoT, multidisciplinary telemedicine, and 5G prehospital emergency.
Further, it provides medical security information platform, DRG/DIP hospital side applications, and single disease quality management control; intelligent health; and city level health services platform and internet plus nursing services.
B-SOFT Co.,Ltd. was founded in 1997 and is headquartered in Hangzhou, China.
Stock analysis
B-Soft Co Ltd (300451) currently trades at ¥2.82, while our estimate is ¥2.81, so the stock looks roughly fairly valued today (gap 0.4%).
Show more
Valuation
None of our valuation models currently applies to this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: ¥2.11 (bear) to ¥3.51 (bull), the price of ¥2.82 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 36/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
B-Soft Co Ltd reported revenue of 1.1B CNY in FY2025 versus 1.9B CNY in FY2021, a compound −13.7%/yr. Reported net income was −402M CNY in FY2025.
Key figures
Market cap 4.2B CNY (≈ $624M) Small · P/S ratio 5.96 · EPS (TTM) ¥-0.37 · Net margin −67.2% · Return on equity −14.5% · Return on assets (EBIT) 0.7% (5-year average) · Operating margin −8.3% · Revenue (TTM) 878M CNY.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 8 out of 100 (low confidence).
What moves the price
The share trades about 57% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −33% fair-value upside, at 0%, 300451 screens cheaper than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Watch 300451, get fair value alerts →
Compare B-Soft Co Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 138 stocks
Valuation Multiplesvs Health Information Services median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Net margin by industry
- P/B ratio by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Chinese Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| HealthEquity, Inc HQY | $94.75 | $104.23 | +10% | vs 300451 |
| Doximity, Inc DOCS | $28.73 | $31.60 | +10% | vs 300451 |
| Waystar Holding WAY | $26.52 | $29.10 | +10% | vs 300451 |
| Veeva Systems Inc VEEV | $266.22 | $289.21 | +9% | vs 300451 |
| Tempus AI, Inc TEM | $54.04 | $36.02 | −33% | vs 300451 |
| HeartFlow, Inc HTFL | $46.69 | $30.50 | −35% | vs 300451 |
| Hinge Health, Inc HNGE | $105.78 | $51.25 | −52% | vs 300451 |
| Pro Medicus Limited PME | A$187.76 | A$82.80 | −56% | vs 300451 |
| BrightSpring Health Services, Inc BTSG | $62.84 | $25.72 | −59% | vs 300451 |
| Privia Health Group PRVA | $25.05 | $5.52 | −78% | vs 300451 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is B-Soft Co Ltd (300451) overvalued or undervalued?
What is the fair value of 300451?
What is the quality score of 300451?
What is the price target for B-Soft Co Ltd (300451)?
What is the B-Soft Co Ltd stock forecast for 2026?
What is the revenue of B-Soft Co Ltd (300451)?
What is the intrinsic value of B-Soft Co Ltd (300451)?
Is B-Soft Co Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 300451?
How much is B-Soft Co Ltd worth?
What do the bullish and bearish scenarios say about 300451?
How solid is the balance sheet of B-Soft Co Ltd (300451)?
How far is 300451 from its 52-week high?
Which stocks are comparable to B-Soft Co Ltd?
Is B-Soft Co Ltd stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of B-Soft Co Ltd (300451)?
What should I pay attention to with B-Soft Co Ltd right now?
Where does the earnings growth of B-Soft Co Ltd (300451) come from?
Key figures of B-Soft Co Ltd
How large is the market capitalisation of B-Soft Co Ltd (300451)?
What is the P/S ratio of B-Soft Co Ltd (300451)?
What are the earnings per share of B-Soft Co Ltd (300451)?
What is the net margin of B-Soft Co Ltd (300451)?
What is the return on equity of B-Soft Co Ltd (300451)?
What is the EBIT return on assets of B-Soft Co Ltd (300451)?
What is the operating margin of B-Soft Co Ltd (300451)?
How fast is revenue growing at B-Soft Co Ltd (300451)?
How fast are earnings growing at B-Soft Co Ltd (300451)?
How much free cash flow does B-Soft Co Ltd (300451) generate?
How much net cash does B-Soft Co Ltd (300451) hold?
Watch B-Soft Co Ltd in the live analysis
One click puts B-Soft Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.